glp-1 news today 2025 october 9 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Spending Hit $5.8 Billion
Description
The following table lays the two ligand classes side by side
2025;4:EVIDoa2500158
Since 2006, glucagon-like peptide-1 receptor (GLP-1R) agonists have caused a dramatic change in the treatment of type 2 diabetes, with clinically relevant and sustained effects on glycaemic control and body weight combined with cardioprotective mechanisms [3, 4]
[DOI] [PMC free article] [PubMed] [Google Scholar] 77.Yaribeygi H., Rashidy-Pour A., Atkin S.L., Jamialahmadi T., Sahebkar A
quarterly newsletter for health professionals
In contrast, GIP positively stimulates glucagon secretion at lower levels of glycaemia (Seino et al, 2010)
